| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/12/2012 | US20120010149 Peptide combination |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/12/2012 | US20120010135 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 01/12/2012 | US20120009259 Formulation for co-therapy treatment of diabetes |
| 01/12/2012 | US20120009258 Compacted cinacalcet |
| 01/12/2012 | US20120009250 Controlled release delivery system for nasal applications |
| 01/12/2012 | US20120009244 NEUROD1 GENE EXPRESSION IN NON-ENDOCRINE PANCREATIC EPITHELIAL CELLS (NEPECs) |
| 01/12/2012 | US20120009229 Pharmaceutical compositions and related methods of delivery |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/11/2012 | EP2403833A1 8-substituted quinolines and related analogs as sirtuin modulators |
| 01/11/2012 | EP1991549B1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 01/11/2012 | EP1468092B1 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/11/2012 | CN102317284A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/11/2012 | CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 01/11/2012 | CN101708317B Chinese medicinal composition for treating thyroid disease |
| 01/11/2012 | CN101607931B Preparation method of calcitriol |
| 01/11/2012 | CN101574338B Pharmaceutical composition for restraining activity of aromatizing enzyme and application thereof |
| 01/11/2012 | CN101522689B Pyridooxazepine progesteron receptor modulators |
| 01/11/2012 | CN101305009B 氮杂取代的螺环衍生物 Aza-substituted spiro derivatives of |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093212 Methods of treating nerve-related vision disorders by an insulinomimetic agent |
| 01/10/2012 | CA2521985C Follicle-stimulating hormone reduction agent |
| 01/10/2012 | CA2508042C Pyridine/pyrazine-2-carboxamide derivatives and uses thereof |
| 01/10/2012 | CA2505389C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 01/10/2012 | CA2483855C Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
| 01/10/2012 | CA2348167C Pharmaceutical administration form for peptides, process for its preparation, and use |
| 01/05/2012 | WO2012000499A1 New polymorphic form of a calcimimetic compound |
| 01/05/2012 | WO2012000498A1 New polymorphic form of a calcimimetic compound |
| 01/05/2012 | US20120005127 Methods for improvement of beta cell function |
| 01/05/2012 | US20120004312 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004271 Use of vaginally-administered insulin sensitizing agents |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/05/2012 | US20120004174 Gh secretagogues and uses thereof |
| 01/05/2012 | US20120004164 Organic compounds |
| 01/05/2012 | US20120003337 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 01/05/2012 | US20120003328 Modified sodium-montmorillonite, preparation method and uses thereof |
| 01/04/2012 | EP2402361A1 Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17-carbothioate and intermediates |
| 01/04/2012 | EP2402360A1 Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17-carbothioate and intermediates |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2401279A1 1, 4-disubstituted piperidines as vasopressin receptor via antagonists |
| 01/04/2012 | EP2400952A2 Composition of a liposomal gel containing hydrocortisone, its metabolites, precursors or mixtures thereof and the use thereof |
| 01/04/2012 | EP1793816B1 Compositions for treating amyloid associated diseases |
| 01/04/2012 | EP1620058B1 Composition for improving cognition and memory |
| 01/04/2012 | CN102307992A Method for treating or preventing a pancreatic dysfunction |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307860A GPR120 receptor agonists and uses thereof |
| 01/04/2012 | CN102307852A Cyclic amine compounds |
| 01/04/2012 | CN102307847A Indanyl compounds |
| 01/04/2012 | CN102307595A Antibodies and methods for treating estrogen receptor-associated diseases |
| 01/04/2012 | CN102304124A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/04/2012 | CN102302720A Chinese medicinal composition for treating hyperthyroidism |
| 01/03/2012 | US8088825 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/03/2012 | US8088377 Human monoclonal antibodies against CD30 |
| 01/03/2012 | CA2671954C Methods for treating or preventing symptoms of hormonal variations |
| 01/03/2012 | CA2529464C Propionamide derivatives useful as androgen receptor modulators |
| 01/03/2012 | CA2514407C Thienopyrimidine compounds and use thereof |
| 01/03/2012 | CA2480423C Truncated 24 kda basic fibroblast growth factor |
| 01/03/2012 | CA2445835C 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 12/29/2011 | WO2011161101A1 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments |
| 12/29/2011 | WO2011160633A1 Glucagon analogues |
| 12/29/2011 | WO2011109367A3 Methods and compositions for treating or preventing symptoms of hormonal variations |
| 12/29/2011 | WO2001035902A3 Stabilized thyroxine compounds |
| 12/29/2011 | US20110319471 Lna antagonists targeting the androgen receptor |
| 12/29/2011 | US20110319458 Compound with agitation effect on peroxisome proliferator-activated receptor. process for its preparation and use thereof |
| 12/29/2011 | US20110319451 5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders |
| 12/29/2011 | US20110319411 Isoindolinone and related analogs as sirtuin modulators |
| 12/29/2011 | US20110319348 Brassinosteroids in treating prostatic hyperplasia and androgenic alopecia |
| 12/29/2011 | US20110319330 Methods For Treating Arthritis, Autoimmune Disease, and Ischemia-Reperfusion Injury |
| 12/29/2011 | US20110319323 Pharmaceutical composition and method of use to improve organ function |
| 12/29/2011 | US20110319317 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt1 |
| 12/29/2011 | US20110318417 Highly pure cinacalcet or a pharmaceutically acceptable salt thereof |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | CA2803690A1 6,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicaments |
| 12/29/2011 | CA2802897A1 Glucagon analogues |
| 12/29/2011 | CA2802889A1 Glucagon analogues |
| 12/28/2011 | EP2399903A1 Ccr9 inhibitors and methods of use thereof |
| 12/28/2011 | EP2399583A1 Use of vaginally-administered insulin sensitizing agents |
| 12/28/2011 | CN102300578A 用于改变健康、安康和寿命的方法和组合物 The method used to change the health, well-being and life and compositions |
| 12/28/2011 | CN102293905A 一种干预青春期生长发育的中药 An intervention in adolescent medicine Growth |
| 12/28/2011 | CN101691410B 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物 Having a role in prevention and treatment of insulin resistance in marine oligosaccharides chromium complexes |
| 12/28/2011 | CN101274012B 夏枯草属植物提取物的组合物、制备方法及其药物用途 Prunella plant extract composition, preparation and pharmaceutical use |
| 12/28/2011 | CN101007000B 异黄酮化合物的制药用途以及含有它们的组合物 Isoflavone compounds and pharmaceutical use of the compositions containing them |
| 12/27/2011 | US8084419 Pharmaceutical compositions for sustained drug delivery |
| 12/27/2011 | US8084053 Dry mouldable drug formulation |
| 12/27/2011 | US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 12/22/2011 | WO2011159297A1 Gpr120 receptor agonists and uses thereof |
| 12/22/2011 | WO2011157793A1 Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 12/22/2011 | WO2011157787A1 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 12/22/2011 | WO2011157443A1 (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one |
| 12/22/2011 | WO2011156908A1 Methods of treating or preventing estrogen-related diseases |
| 12/22/2011 | US20110313000 Ccr9 inhibitors and methods of use thereof |
| 12/22/2011 | US20110312995 Bridged and fused heterocyclic antidiabetic compounds |
| 12/22/2011 | US20110312970 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 12/22/2011 | US20110312958 Modulators of atp-binding cassette transporters |